Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Sciences Capital (LSC) was a New York-based specialized finance company that provided venture debt and venture leases to emerging private and public companies within the life sciences sector. Founded in 2007 as a subsidiary of Emigrant Bank, the firm focused on supporting growth in the biotechnology, pharmaceutical, and medical device industries by offering non-dilutive capital solutions. LSC's investment portfolio included companies such as Advanced Accelerator Applications and MDG Medical, helping them reach key clinical and commercial milestones. The firm was managed by a team with backgrounds in both the sciences and corporate finance, leveraging its parent company's resources for dependable funding. Life Sciences Capital officially ceased its operations on February 18, 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life Sciences Capital.